Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Reduced-intensity Conditioning
100%
Thrombotic Microangiopathy
100%
Stem Cell Transplantation
46%
Risk Factors
20%
Myeloablative Conditioning
20%
Clinical Setting
13%
Fludarabine
13%
Graft-versus-host Disease (GvHD)
13%
In(III)
6%
High Dose
6%
Multivariate Model
6%
Toxic Effects
6%
Mortality Rate
6%
Patient Characteristics
6%
Response to Therapy
6%
Well-defined
6%
Transplantation
6%
Chemoradiotherapy
6%
Unrelated Donor
6%
Patients at Risk
6%
Univariate Analysis
6%
Common Complications
6%
Advanced Disease
6%
Single Center
6%
Peri
6%
High-risk Areas
6%
Endothelial Cell Injury
6%
Severe Complications
6%
Characteristic Response
6%
Clinical Risk
6%
Active Disease
6%
Nonmyeloablative
6%
Endothelial Damage
6%
Heavily Pretreated Patients
6%
Diffuse Alveolar Hemorrhage
6%
Hepatic Graft-versus-host Disease
6%
Setting Factors
6%
Medicine and Dentistry
Microangiopathy
100%
Allogeneic Stem Cell Transplantation
100%
Reduced Intensity Conditioning
100%
Stem Cell Therapy
40%
Graft Versus Host Reaction
13%
Fludarabine
13%
Nonmyeloablative Conditioning
13%
Disease
6%
Cell Damage
6%
Mortality Rate
6%
Endothelial Cell
6%
Drug Megadose
6%
Univariate Analysis
6%
Patient Characteristics
6%
Liver Graft
6%
Chemoradiotherapy
6%
Toxicity
6%
Pulmonary Hemorrhage
6%
Acute Graft Versus Host Disease
6%
Myeloablative Conditioning
6%
Patient History of Stem Cell Transplantation
6%
Biochemistry, Genetics and Molecular Biology
Conditioning
100%
Allogeneic Stem Cell Transplantation
100%
Thrombotic Microangiopathy
100%
Stem Cell Transplantation
46%
Host
20%
Fludarabine
13%
Mortality Rate
6%
Cell Damage
6%
Drug Megadose
6%
Pharmacology, Toxicology and Pharmaceutical Science
Microangiopathy
100%
Fludarabine
13%
Graft Versus Host Reaction
13%
Disease
6%
Mortality Rate
6%
Injury
6%
Toxicity
6%
Chemoradiation Therapy
6%
Lung Hemorrhage
6%
Acute Graft Versus Host Disease
6%
Patient History of Stem Cell Transplantation
6%